Ms Belinda Dee Van Allen, CDC, RRW | |
7281 Garden Grove Blvd Ste H, Garden Grove, CA 92841-4212 | |
(714) 539-4544 | |
(714) 539-5483 |
Full Name | Ms Belinda Dee Van Allen |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 7281 Garden Grove Blvd Ste H, Garden Grove, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639262611 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
101YA0400X | Counselor - Addiction (substance Use Disorder) | RW0905 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Belinda Dee Van Allen, CDC, RRW 8265 Garden Grove Blvd, Garden Grove, CA 92844-1010 Ph: (714) 539-4544 | Ms Belinda Dee Van Allen, CDC, RRW 7281 Garden Grove Blvd Ste H, Garden Grove, CA 92841-4212 Ph: (714) 539-4544 |
News Archive
Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve (ASPN), January 12-18, 2011, Cancun Mexico.
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
China's leading food and nutritional ingredient show returns to Shanghai this June with more exhibitors, features, visitors, ingredients and opportunities.
Aetna today released the following statement from Chairman and CEO Ronald A. Williams regarding the six-month anniversary of the passage of the Patient Protection and Affordable Care Act (PPACA).
A pair of drugs that may be a one-two punch needed to help combat acute myeloid leukemia (AML), an aggressive blood cancer that kills nearly three-fourths of patients within five years of diagnosis, is the focus of a new multi-center clinical trial that will enroll patients at three sites across the U.S.
› Verified 3 days ago
Ms. Hieu Doan Pham, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 12371 Lewis St Ste 202, Garden Grove, CA 92840 Phone: 657-203-2472 | |
Julian Jesus Castillo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12141 Brookhurst St Ste 201, Garden Grove, CA 92840 Phone: 657-261-7140 Fax: 714-922-1032 | |
Caleb Andrew Weber, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12755 Brookhurst St, Garden Grove, CA 92840 Phone: 714-638-8277 | |
Jasson Vega, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12141 Brookhurst St, Garden Grove, CA 92840 Phone: 714-296-1934 | |
Ms. Linda Sue Cooley, CATC, RADI Counselor Medicare: Not Enrolled in Medicare Practice Location: 12800 Garden Grove Blvd Ste F, Garden Grove, CA 92843 Phone: 714-620-8131 | |
Robert Brian Braithwaite, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12755 Brookhurst St, Ste114, Garden Grove, CA 92840 Phone: 714-638-8277 | |
Kelly Chau Quach, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 14411 Brookhurst St Ste D & E, Garden Grove, CA 92843 Phone: 714-548-7202 |